Unrated Drug recall · FDA · Published October 14, 2021

Ezetimibe and Simvastatin Tablets Recall: Foreign Tablets Risk

Golden State Medical Supply recalls Ezetimibe and Simvastatin 10mg/40mg tablets due to foreign tablets found in some batches. This could cause harm if taken.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0227-2022Drug Golden State Medical Supply ›

Recall notice

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Take action

Contact the company

Recalling firmGolden State Medical Supply Inc.5187 Camino Ruiz · Camarillo, CA 93012-8601

✎ GovInfoNow plain-language explainer

Golden State Medical Supply is recalling certain Ezetimibe and Simvastatin tablets because foreign tablets were found in some batches. This could cause harm if taken by patients. Read more at govinfonow.com/recall/35647-ezetimibe-and-simvastatin-tablets-recall-foreign-tablets-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/35647-ezetimibe-and-simvastatin-tablets-recall-foreign-tablets-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0227-2022

Cite this page

“Ezetimibe and Simvastatin Tablets Recall: Foreign Tablets Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35647-ezetimibe-and-simvastatin-tablets-recall-foreign-tablets-risk. Based on FDA recall #D-0227-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0227-2022%22&limit=1).

The FDA announced on Oct. 14, 2021, that Golden State Medical Supply Inc. is recalling Ezetimibe and Simvastatin Tablets due to failed excipient specifications and the presence of foreign tablets. The recall involves lots manufactured by Dr. Reddy's Laboratories.

How to tell if you have it

Brand: Golden State Medical Supply
Product: Ezetimibe and Simvastatin Tablets, 10 mg/40mg
NDC: 51407-192-90 (90 Tablets), 51407-192-05 (500 tablets)
Lot GS038610, Exp: 01/2023
Lot GS038891, Exp: 1/2023

The hazard

The product was manufactured using an excipient found to be out of specification for conductivity. Additionally, some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, were found in the bottle.

Context

GovInfoNow's records show Golden State Medical Supply Inc. has 31 other recalls on record since April 14, 2014. Other recent recalls of similar products include Prasugrel HCl 10mg Tablets (Aug. 21, 2026), Carbamazepine 200mg tablets (Aug. 7, 2026), and NIACIN Extended-Release Tablets (May 29, 2026).

How to tell if you have this one

Check the product label for the lot number: a) Lot GS038610 (expires Jan 2023) or b) Lot GS038891 (expires Jan 2023). The product is prescription-only.

Brand
Golden State Medical Supply
Category
Drug

FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Classification
Class II
Status
Terminated
Distribution
Distributed to two distributors located in AZ and MO
NDC
51407-190-30, 51407-190-90, 51407-190-10, 51407-191-30, 51407-191-90, 51407-191-10, 51407-192-30, 51407-192-90, 51407-192-05, 51407-192-10, 51407-193-30, 51407-193-90, 51407-193-05

Recall number	Product, codes & lots	Quantity
D-0227-2022	Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05; a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023	a) 101 b) 145 bottles
D-0228-2022	Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC 51407-193-05; GS040048, Exp: 1/2023	49

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for the lot number on the label: a) GS038610 (expires Jan 2023) or b) GS038891 (expires Jan 2023).

Where it went and when

Where it was distributed

Distributed in Arizona and Missouri.

FDA distribution: “Distributed to two distributors located in AZ and MO” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona, Missouri.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

Oct 14, 2021Firm started the recall
Nov 9, 2021FDA classified it Class II
Nov 17, 2021Published in FDA’s Enforcement Report
Nov 10, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Golden State Medical Supply recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35647-ezetimibe-and-simvastatin-tablets-recall-foreign-tablets-risk">Ezetimibe and Simvastatin Tablets Recall: Foreign Tablets Risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0227-2022 (October 14, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0227-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.